ATE234831T1 - 1,4-disubstituierte piperazine - Google Patents

1,4-disubstituierte piperazine

Info

Publication number: ATE234831T1
Authority: AT; Austria
Prior art keywords: insulin; treatment; present; disubstituted piperazine; hyperalgesic
Prior art date: 1996-10-04

Application number

AT97941884T

Other languages

English (en)

Inventor

Rolf Hohlweg

Peter Madsen

Tine Krogh Jorgensen

Knud Erik Andersen

Brett Watson

Zdenek Polivka

Otylie Konigova

Alexandra Silhankova

Vladimir Valenta

Original Assignee

Novo Nordisk As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-04

Filing date

1997-10-02

Publication date

2003-04-15

1997-10-02 Application filed by Novo Nordisk As filed Critical Novo Nordisk As

2003-04-15 Application granted granted Critical

2003-04-15 Publication of ATE234831T1 publication Critical patent/ATE234831T1/de

Links

-1 1,4-DISUBSTITUTED PIPERAZINE Chemical class 0.000 title abstract 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 2
102000004877 Insulin Human genes 0.000 abstract 1
108090001061 Insulin Proteins 0.000 abstract 1
208000007920 Neurogenic Inflammation Diseases 0.000 abstract 1
208000008589 Obesity Diseases 0.000 abstract 1
230000032683 aging Effects 0.000 abstract 1
230000000917 hyperalgesic effect Effects 0.000 abstract 1
230000004968 inflammatory condition Effects 0.000 abstract 1
230000004054 inflammatory process Effects 0.000 abstract 1
229940125396 insulin Drugs 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
208000004296 neuralgia Diseases 0.000 abstract 1
235000020824 obesity Nutrition 0.000 abstract 1
230000001991 pathophysiological effect Effects 0.000 abstract 1
102000004196 processed proteins & peptides Human genes 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
230000028327 secretion Effects 0.000 abstract 1
210000001170 unmyelinated nerve fiber Anatomy 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/76—Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members
- C07C2603/78—Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members containing seven-membered rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Hematology (AREA)
Neurosurgery (AREA)
Emergency Medicine (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Endocrinology (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyridine Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

AT97941884T 1996-10-04 1997-10-02 1,4-disubstituierte piperazine ATE234831T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DK109096		1996-10-04
PCT/DK1997/000422 WO1998015548A1 (en)	1996-10-04	1997-10-02	1,4-disubstituted piperazines

Publications (1)

Publication Number	Publication Date
ATE234831T1 true ATE234831T1 (de)	2003-04-15

Family

ID=8100883

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT97941884T ATE234831T1 (de)	1996-10-04	1997-10-02	1,4-disubstituierte piperazine

Country Status (20)

Country	Link
US (4)	US5916889A (de)
EP (1)	EP0934312B1 (de)
JP (1)	JP2001502307A (de)
KR (1)	KR20000048899A (de)
CN (1)	CN1088459C (de)
AT (1)	ATE234831T1 (de)
AU (1)	AU740662B2 (de)
BR (1)	BR9712196A (de)
CA (1)	CA2267835A1 (de)
CZ (1)	CZ114099A3 (de)
DE (1)	DE69720021T2 (de)
DK (1)	DK0934312T3 (de)
ES (1)	ES2194217T3 (de)
HU (1)	HUP0000090A3 (de)
IL (1)	IL129123A (de)
NO (1)	NO991565L (de)
PL (1)	PL188338B1 (de)
RU (1)	RU2188197C2 (de)
WO (1)	WO1998015548A1 (de)
ZA (1)	ZA978864B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2001501629A (ja) *	1996-10-04	2001-02-06	ノボノルディスクアクティーゼルスカブ	Ｎ―置換アザ複素環式化合物
US6613905B1 (en) *	1998-01-21	2003-09-02	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use therefor
US7045519B2 (en)	1998-06-19	2006-05-16	Chiron Corporation	Inhibitors of glycogen synthase kinase 3
ATE274510T1 (de)	1998-06-19	2004-09-15	Chiron Corp	Glycogen synthase kinase 3 inhibitoren
US7541365B2 (en)	2001-11-21	2009-06-02	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use therefor
US20040038861A1 (en) *	2001-11-26	2004-02-26	Cooper Garth J. S.	Methods and compositions for normalizing lipid levels in mammalian tissues
TWI291467B (en)	2002-11-13	2007-12-21	Millennium Pharm Inc	CCR1 antagonists and methods of use therefor
WO2006034474A2 (en) *	2004-09-23	2006-03-30	Reddy Us Therapeutics, Inc.	Novel pyridine compounds, process for their preparation and compositions containing them
FR2885616B1 (fr) *	2005-05-12	2007-06-22	Servier Lab	Nouveaux derives de phenylpyridinylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2885615B1 (fr) *	2005-05-12	2007-06-22	Servier Lab	Nouveaux derives de phenylpyridinylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
BRPI0618643A2 (pt)	2005-11-09	2011-09-06	Combinatorx Inc	composição compreendendo um par de fármacos, composição compreendendo um corticosteróide e um imunossupressor dependente de imunofilina não-esteróide, kits e uso
NZ608343A (en) *	2007-04-13	2014-09-26	Southern Res Inst	Anti-angiogenic agents and methods of use
CN103086898B (zh) *	2012-07-11	2015-04-08	山东道可化学有限公司	二苯胺或其环上取代的衍生物的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE568611A (de) *	1957-07-18
GB1013901A (en) *	1962-01-26	1965-12-22	Kefalas As	Dihydroanthracene, dibenzocycloheptadiene and dibenzocycloheptatriene derivatives
FR88751E (de) *	1963-07-09	1967-06-07
US3435073A (en) *	1966-04-19	1969-03-25	Colgate Palmolive Co	5-(n-benzyl-n-lower alkylaminoalkylene)-5h-dibenzo(a,d)cycloheptenes
GB1347935A (en) *	1971-04-10	1974-02-27	Yoshitomi Pharmaceutical	Piperazine derivatives methods for their production and phar maceutical compositions containing them
FR2186249A1 (en) *	1972-05-31	1974-01-11	Synthelabo	Phenyl piperazinoalkyl (dihydro)dibenzazepines - antidepressants having low toxicity
HU174126B (hu) *	1977-08-02	1979-11-28	Egyt Gyogyszervegyeszeti Gyar	Sposob poluchenija novykh proizvodnykh dibenzo-kvadratnaja skobka-d,g-kvadratnaja skobka zakryta-kvadratnaja skobka-1,3,6-kvadratnaja skobka zakryta-dioksazocina
ES8502099A1 (es) *	1983-08-02	1984-12-16	Espanola Farma Therapeut	Procedimiento de obtencion de nuevos compuestos derivados de la difenil-metilen-etilamina.
US4994463A (en) *	1987-12-14	1991-02-19	Kyowa Hakko Kogyo Co., Ltd.	Tricyclic thromboxane A2 antagonists
NZ238629A (en) *	1990-06-22	1993-09-27	Schering Corp	Bis-benzo- or benzopyrido-cyclohepta (where z is c, o, s or n) piperidine, piperidylidene or piperazine compounds, medicaments and methods of preparation
KR0167085B1 (ko) *	1990-06-22	1999-01-15	우에하라 아끼라	나프토티오피라논 유도체
MY113463A (en) *	1994-01-04	2002-03-30	Novo Nordisk As	Novel heterocyclic compounds
UA54385C2 (uk) *	1995-04-07	2003-03-17	Ново Нордіск А/С	N-заміщені азагетероциклічні карбонові кислоти та їх ефіри, спосіб їх одержання, фармацевтична композиція та спосіб лікування
PL186708B1 (pl) *	1995-09-19	2004-02-27	Novo Nordisk As	Nowe związki heterocykliczne, sposób ich wytwarzania, kompozycje je zawierające oraz ich stosowaniedo wytwarzania leków

1997
- 1997-10-02 AT AT97941884T patent/ATE234831T1/de not_active IP Right Cessation
- 1997-10-02 IL IL12912397A patent/IL129123A/en not_active IP Right Cessation
- 1997-10-02 WO PCT/DK1997/000422 patent/WO1998015548A1/en not_active Ceased
- 1997-10-02 EP EP97941884A patent/EP0934312B1/de not_active Expired - Lifetime
- 1997-10-02 CN CN97199184A patent/CN1088459C/zh not_active Expired - Fee Related
- 1997-10-02 BR BR9712196-7A patent/BR9712196A/pt not_active IP Right Cessation
- 1997-10-02 DK DK97941884T patent/DK0934312T3/da active
- 1997-10-02 HU HU0000090A patent/HUP0000090A3/hu unknown
- 1997-10-02 PL PL97332597A patent/PL188338B1/pl not_active IP Right Cessation
- 1997-10-02 RU RU99109024/04A patent/RU2188197C2/ru not_active IP Right Cessation
- 1997-10-02 CZ CZ991140A patent/CZ114099A3/cs unknown
- 1997-10-02 KR KR1019990702928A patent/KR20000048899A/ko not_active Ceased
- 1997-10-02 JP JP10517093A patent/JP2001502307A/ja not_active Ceased
- 1997-10-02 CA CA002267835A patent/CA2267835A1/en not_active Abandoned
- 1997-10-02 DE DE69720021T patent/DE69720021T2/de not_active Expired - Fee Related
- 1997-10-02 ES ES97941884T patent/ES2194217T3/es not_active Expired - Lifetime
- 1997-10-02 AU AU43772/97A patent/AU740662B2/en not_active Ceased
- 1997-10-03 US US08/943,726 patent/US5916889A/en not_active Expired - Fee Related
- 1997-10-03 ZA ZA9708864A patent/ZA978864B/xx unknown
1999
- 1999-03-18 US US09/271,785 patent/US6004961A/en not_active Expired - Fee Related
- 1999-03-18 US US09/271,564 patent/US6133268A/en not_active Expired - Fee Related
- 1999-03-18 US US09/271,565 patent/US6040302A/en not_active Expired - Fee Related
- 1999-03-30 NO NO991565A patent/NO991565L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
BR9712196A (pt)	1999-08-31
DE69720021T2 (de)	2004-02-05
KR20000048899A (ko)	2000-07-25
US6004961A (en)	1999-12-21
NO991565L (no)	1999-06-04
NO991565D0 (no)	1999-03-30
CA2267835A1 (en)	1998-04-16
US6040302A (en)	2000-03-21
ES2194217T3 (es)	2003-11-16
CN1234799A (zh)	1999-11-10
EP0934312A1 (de)	1999-08-11
CZ114099A3 (cs)	1999-09-15
RU2188197C2 (ru)	2002-08-27
IL129123A (en)	2004-07-25
US6133268A (en)	2000-10-17
EP0934312B1 (de)	2003-03-19
US5916889A (en)	1999-06-29
AU4377297A (en)	1998-05-05
WO1998015548A1 (en)	1998-04-16
PL332597A1 (en)	1999-09-27
CN1088459C (zh)	2002-07-31
ZA978864B (en)	1998-04-06
IL129123A0 (en)	2000-02-17
PL188338B1 (pl)	2005-01-31
JP2001502307A (ja)	2001-02-20
HUP0000090A2 (hu)	2001-04-28
AU740662B2 (en)	2001-11-08
DE69720021D1 (de)	2003-04-24
HUP0000090A3 (en)	2002-01-28
DK0934312T3 (da)	2003-07-21

Legal Events

Date	Code	Title	Description
2003-09-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE234831T1 (de)	2003-04-15	1,4-disubstituierte piperazine
ATE469161T1 (de)	2010-06-15	Pyrazolderivat, dieses enthaltende medizinische zusammensetzung, medizinische verwendung davon, und zwischenprodukt für dessen herstellung
YU4397A (sh)	1999-09-27	Novi supstituisani oksazolidinoni
IS8058A (is)	2005-09-30	Sýklísk súlfónamíð til að hamla gamma seytiasa
DK0738262T3 (da)	2000-09-04	Hidtil ukendte heterocykliske forbindelser
NO20045281L (no)	2005-02-01	Tiazolidinoner og anvendelse derav som polo-lignende kinaseinhibitorer
TNSN00200A1 (fr)	2002-05-30	Derives d'ethers de biaryle nouveaux, compositions les contenant et leur utilisation
BR0009563A (pt)	2002-01-15	Inibidores de ap2 de bifenilas contendo heterocìclico e método
FR2776510B1 (fr)	2002-11-29	Derives de polyamino-acides et leur utilisation dans des compositions de traitement des fibres keratiniques
BRPI0111639B8 (pt)	2021-05-25	uso de uma molécula de ácido oligodeoxinucléico imunoestimulatório e composição farmacêutica.
KR950016744A (ko)	1995-07-20	트롬빈을 저해하는 방법
NO990667L (no)	1999-04-12	Depeptid-benzamidin som kinogenase-inhibitor
AR024634A1 (es)	2002-10-16	Composicion farmaceutica estabilizada en forma liofilizada
ATE147071T1 (de)	1997-01-15	1,4-disubstituierte piperidinderivate, ihre herstellung und therapeutische verwendung
NZ516290A (en)	2004-03-26	Substituted phenoxyacetic acids
AR002741A1 (es)	1998-04-29	Benciloxicarbonilguanidinas sustituidas, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico asi como medicamentoque las contiene
PT906272E (pt)	2003-10-31	Peptidos
BG106847A (bg)	2003-02-28	Заместени пиперазинови производни като инхибиторина микрозомалния триглицеридпренасящ протеин (mtp)
WO1999047517A8 (en)	1999-11-25	Novel heterocyclic compounds
YU80501A (sh)	2004-09-03	Endoparaziticidne kompozicije
ATE293591T1 (de)	2005-05-15	Neue n-(2-phenyl-3-aminopropyl)naphtamide
NO970783L (no)	1997-02-20	Fremgangsmåte for å hindre endometrialkreft
ATE186214T1 (de)	1999-11-15	Verwendung von rosmanolderivaten zur herstellung von antiradikalischen und/oder antilipoperoxidativen und/oder hepatotropen arzneistoffen
AR037963A1 (es)	2004-12-22	Piperidin-2,6-diona sustituida con heterociclo en la posicion 3, procedimiento para prepararla, medicamento que la contiene y su uso para preparar este ultimo
ATE298564T1 (de)	2005-07-15	Arzneimittelformulierung enthaltend einen ltb4 antagonisten und einen netzmittel